RA Capital Management is a multi-stage investment firm primarily focused on evidence-based investing in healthcare, biotechnology, and life science companies developing drugs, medical devices, diagnostics, services, and research tools. The firm also invests in planetary health, supporting companies from discovery through commercialization in both public and private markets.
Portfolio
3
Fund Size
$12.6B
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Commons Clinic | Series A | $19.5M | Oct 2023 |
| Freenome | Series D | $300M | Dec 2021 |
| Avalanche Energy | Series B | $29M | — |
Top Co-Investors
Congruent Ventures1 shared
Founders Fund1 shared
Lowercarbon Capital1 shared
Perceptive Advisors1 shared
Bain Capital Life Sciences1 shared
Catalio Capital Management1 shared
Cormorant Asset Management1 shared
DCVC1 shared
GV (Google Ventures)1 shared
Janus Henderson Investors1 shared
Kaiser Permanente Ventures1 shared
Novartis Venture Fund1 shared
Polaris Venture Partners1 shared
Sands Capital1 shared
Section 321 shared
T. Rowe Price Associates, Inc.1 shared
Eventide Asset Management1 shared
Logos Capital1 shared
Pura Vida Investments1 shared
Floating Point1 shared
Last updated: 27 February 2026